Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Quentin30

<< Previous

Bullboard Posts

Next >>

Comment by fox7mfon Sep 21, 2023 3:41pm

184 Views

Post# 35648023

RE:RE:RE:Quentin30

Many stock discussion boards have little discourse happening because nothing is happening with the featured company. There are a lot of longs/backers here in discussion because the science is strong and a partnership/buyout is close. There are also a lot of bashers. Why? Because the science is strong and a partnership/buyout is close and their hedge fund employers want as many shares as possible. Take the presence of these dimwits as a positive.

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading